We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Synthetic Nanoparticle Vaccine Confers Long-Term Protection Against Respiratory Syncytial Virus Infection

By LabMedica International staff writers
Posted on 19 Aug 2015
Print article
Image: Electron micrograph showing the respiratory syncytial virus (RSV) pathogen. RSV is a negative-sense, enveloped RNA virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Electron micrograph showing the respiratory syncytial virus (RSV) pathogen. RSV is a negative-sense, enveloped RNA virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
A team of molecular virologists and immunologists has shown that alveolar macrophages (AMs) play an important role in immune protection following vaccination against respiratory syncytial virus (RSV) by controlling eosinophils, mucus production, inflammatory cytokines, and T-cell infiltration.

Alveolar macrophages are phagocytes that play a critical role in homeostasis, host defense, the response to foreign substances, and tissue remodeling. Since alveolar macrophages are pivotal regulators of local immunological homeostasis, their population density is decisive for the many processes of immunity in the lungs. They are highly adaptive components of the innate immune system and can be specifically modified to whatever functions needed depending on their state of differentiation and micro-environmental factors encountered. Alveolar macrophages release numerous secretory products and interact with other cells and molecules through the expression of several surface receptors.

Investigators at Georgia State University (Atlanta, USA) studied the role of alveolar macrophages in the immune response mounted by mice that had been vaccinated against RSV with a vaccine comprising either fusion and glycoprotein virus-like nanoparticles (FG VLPs) or formalin-inactivated RSV (FI-RSV). The FG VLP vaccine is currently being evaluated for possible use in humans while the FI-RSV vaccine had been studied and rejected in the 1960s because it caused severe vaccine-enhanced respiratory disease.

In the current study mice were infected with a live RSV pathogen one year after vaccination. In some of the animals the apoptosis-inducing agent clodronate liposomes (CLs) was used to deplete tissue macrophages in order to focus on the role of the alveolar macrophages.

Results published in the July 14, 2015, online edition of the International Journal of Nanomedicine revealed that animals vaccinated with FG VLPs showed no obvious signs of severe pulmonary disease upon RSV infection and displayed significantly lower levels of eosinophils, T-cell infiltration, and inflammatory cytokines. These mice had much higher levels of anti-RSV antibodies and interferon-gamma antiviral cytokine, which are correlated with protection against RSV disease.

In comparison, mice vaccinated with FI-RSV and then treated with clodronate liposomes demonstrated increases in eosinophils, plasmacytoid dendritic cells, interleukin-4 T-cell infiltration, proinflammatory cytokines, chemokines, and mucus production upon RSV infection. FI-RSV immune mice showed severe pulmonary disease in tissue examinations.

The results obtained in this study suggest that FG nanoparticle vaccination induced long-term protection against RSV and that AMs played a role in protection against RSV by modulating eosinophilia, mucus production, inflammatory cytokines, and T-cell infiltration.

"Recombinant engineered nanoparticle vaccines might be developed to prevent highly contagious respiratory pathogens such as RSV, as reported in this study," said senior author Dr. Sang-Moo Kang, professor of biomedical sciences at Georgia State University.

Related Links:

Georgia State University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.